Epstein Secrets

degree in business administration, and she was placed on a senior management track at AT&T. She then went on to lead a spin-off of Lucent. In 1998, Fortune Magazine named her the "most powerful woman in American business," largely as a result of her role with the spin-off. Recruiters, including from HP, began c

huge profits. Gilead, maker of Sovaldi, has profits of around 5o percent. Biogen, Amgen and other biotech firms have profits of around 30 percent. Merck and Pfizer are seeing profits of 18 percent or more. Even if profits were cut by a third or a half, there would be sufficient incentive to assume th

Editor Jacob H. Schiff Professor of Investment Banking D. Swarovski KG USA Newmont Mining Corporation Berlingske Tidende AS Intel Corporation Fortune Magazine OPOWER Alcoa Inc. A.T. Keamey Inc. GetJar Areva Jumeirah Group Harvard Kennedy School Clifford Chance LLP Olayan Europe Ltd Seesmic Univer

Secretary-General Chief Executive Officer Chief Executive Officer Managing Director, Legal and Risk Professor of Management Practice President, Merck Vaccines Director, Center for Public Leadership Artistic and General Director Managing Partner, Strategy and Business Development Managing Direc

esident, Intel Capital and Intel Corporation USA Managing Director Juan Mario Laserna Senator, Colombia Adam Lashinsky Senior Editor-at-Large Fortune Magazine USA Alex Laskey President OPOWER USA Vanessa Lau Group Chief Financial Officer. Alcoa Alcoa Inc. USA Global Rolled Products Paul A. Laudic

and Risk Credit Suisse USA William W. George Professor of Management Practice Harvard Business School USA Julie Louise Gerberding President, Merck Vaccines Merck & Co. Inc. USA David R. Gergen Director, Center for Public Leadership Harvard Kennedy School USA Valery Gergiev Artistic and G

esident, Intel Capital and Intel Corporation USA Managing Director Juan Mario Laserna Senator, Colombia Adam Lashinsky Senior Editor-at-Large Fortune Magazine USA Alex Laskey President OPOWER USA Vanessa Lau Group Chief Financial Officer. Alcoa Alcoa Inc. USA Global Rolled Products Paul A. Laudic

and Risk Credit Suisse USA William W. George Professor of Management Practice Harvard Business School USA Julie Louise Gerberding President, Merck Vaccines Merck & Co. Inc. USA David R. Gergen Director, Center for Public Leadership Harvard Kennedy School USA Valery Gergiev Artistic and G

cal USA Center and Health System Warren East Chief Executive Officer Arm Holdings Plc United Kingdom Nina Easton Senior Editor and Columnist Fortune Magazine USA World Economic Forum Annual Meeting EFTA_R1_02105170 EFTA02707402 Joseph Echevarria Paul N. Eckley Chief Executive Officer Senior Vice-P

iness School Google Inc. USA USA Germany Switzerland USA USA World Economic Forum Annual Meeting EFTA_R1_02105175 EFTA02707407 President, Merck Vaccines MSD USA Julie Louise Gerberding Mikhail Gerchuk Mohammad Abdullah Al Gergawi David R. Gergen Valery Gergiev Natalia Germanova Ola